Prognose

Das durchschnittliche Kursziel der Analysten beträgt +44,39€(+7,80%). Der Median liegt bei +42,98€(+4,37%).

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

QGEN or EXAS: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Qiagen (QGEN) or Exact Sciences (EXAS). But which of these two stocks presents investors with the better value opportunity right now?» Mehr auf zacks.com
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. to release results for Q2 2025 and hold webcast.» Mehr auf businesswire.com
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board has elected Stephen H. Rusckowski as Chairman following the Annual General Meeting of Shareholders (AGM) on June 26, 2025. He succeeds Lawrence A. Rosen, who did not stand for re-election after serving for 12 years on the Supervisory Board. The Dutch Corporate Governance Code indicates that Directors of public companies should not serve more than 12 years for a.» Mehr auf businesswire.com

In 2025 hat Qiagen NV bereits 0,25€ Dividende ausgeschüttet. Die letzte Dividende wurde im Juli gezahlt.

Im letzten Quartal hatte Qiagen NV einen Umsatz von 446,89 Mio€ und ein Nettoeinkommen von 83,89 Mio€